Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau

Aaby, P; Gustafson, P; Roth, A; Rodrigues, A; Fernandes, M; Sodemann, M; Holmgren, B; Benn, CS; Garly, M.-, L; Lisse, IM; Jensen, H; (2006) Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine, 24 (29-30). pp. 5718-5725. ISSN 0264-410X DOI:

Full text not available from this repository.


BACKGROUND: Live vaccines including BCG and measles may have non-targeted beneficial effects on childhood survival in areas with high mortality. The authors therefore undertook a survey of vaccinia scars to evaluate subsequent mortality. SUBJECTS: Based on a population census, a cohort of 1893 adults in urban Guinea-Bissau was examined in 1998 and followed until 2002. MAIN OUTCOME MEASURE: All cause mortality, excluding accidents. RESULTS: The median age of vaccinia vaccinations had been 16-18 years. Adults with a vaccinia scar had a mortality ratio (MR) of 0.60 (0.41-0.87) compared to those without any scar. The effect was stronger for women. Mortality decreased with each additional vaccinia scar (MR=0.73 (0.56-0.95)). Among 502 individuals with information on HIV infection, the age-adjusted HIV-2 prevalence was 2.45 (1.06-5.65) for those with a vaccinia scar. Control for district, ethnic group, schooling, place of birth, quality of housing and HIV status had little effect on the estimate. Since vaccinia and BCG scars could have been confused, mortality for adults with vaccinia and/or BCG scar was compared to those without, the MR being 0.61 (0.41-0.89). CONCLUSION: Known cultural or socio-economic factors possibly associated with access to vaccination had no influence on the mortality ratio for having a vaccinia scar. Hence, vaccinia vaccination may have a prolonged beneficial effect on adult survival.

Item Type: Article
Keywords: Adult, Aged, BCG Vaccine, Female, Guinea-Bissau, HIV Infections, HIV-2, Humans, Male, Middle Aged, Smallpox Vaccine, Survival Analysis, Vaccination, Vaccinia virus, Adult, Aged, BCG Vaccine, administration & dosage, Female, Guinea-Bissau, epidemiology, HIV Infections, mortality, HIV-2, Humans, Male, Middle Aged, Smallpox Vaccine, administration & dosage, Survival Analysis, Vaccination, Vaccinia virus, immunology
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Vaccine Centre
PubMed ID: 16720061
Web of Science ID: 239081600008


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item